Epstein barr virus encodes miRNAs


On behalf of the Journal of Molecular Cancer, as Editor-in-Chief, it is my distinct honour and privilege to welcome you.

The Journal of Molecular Cancer aims to disseminate knowledge and advance discussion through the publication of peer-reviewed, high quality research papers on all topics related to Molecular Cancer. Huge accentuation is laid on the current trends in Molecular cancer research along with key significant themes of chemistry. . The open access journal is published by Pulsus Publishing who hosts around 215 open access peer-reviewed journals as well as organizes more than 100 International scientific Conferences.

Epstein-barr virus (EBV) is a definite tumorigenic virus, which can form life-long latency in the host, which is difficult to be recognized and completely eliminated by the immune system. It is closely related to the occurrence and development of nasopharyngeal cancer, gastric cancer and various types of lymphoma. At present, a total of 44 Epstein-barr virus-encoded microRNAs (EBV miRNAs) have been found. In response to the immune system of the body, EBV miRNAs can inhibit the expression and presentation of viral antigens, inhibit immune activation and immunotoxicity, assisting host cells to escape from immunity, and providing conditions for further immortalized tumorigenesis of the host cells.

The Journal emphasizes high-level research and education. We invite various Article like Original research articles, reviews, short communications and letters to the editors in the fields of Molecular cancer are invited. Every effort is made to have a rapid and critical peer-review process.

Manuscripts can be uploaded at Online Manuscript Submission System

Julia Gillard
Managing Editor
Journal of Molecular Cancer
Whats App: +1-947-33-4405